CanSino falls behind in race to develop Covid-19 vaccine
CanSino was supposed to have sent its vaccine candidate, developed with Canadian tech, to Canada already so final-stage tests could begin there
Moscow/Vancouver — One of the world’s fastest-moving efforts to develop a Covid-19 vaccine is falling behind rivals, its advance appearing to be stymied by political tension between China and Canada and concerns its shot may not work as well as others.
CanSino Biologics, the Chinese company which in March started the world’s first human tests on an experimental coronavirus shot, has yet to start administering shots in critical final-stage trials on the vaccine it developed with the Chinese military. Meanwhile, rivals such as US-based Moderna and Britain’s AstraZeneca as well as China’s Sinovac Biotech and Sinopharm are well into this last phase of testing, giving test inoculations to thousands of people to find out if they work...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.